Join Now

Author Archives: Natalie Themm

DiscGenics Honored by Goldman Sachs for Entrepreneurship

BioUtah member Discgenics Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit.

Posted in BioUtah News | Tagged | Leave a comment

BioUtah Kicks-Off the 2021 Virtual BioHive Summit with Dr. Dean Li, President, Merck Research Laboratories

The BioHive Summit, powered in partnership with BioUtah, on Nov. 12 will live stream a distinguished line-up of speakers and panelists from inside and outside Utah’s burgeoning life sciences industry.

Posted in BioUtah News | Tagged , | Leave a comment

New WTC Utah Grants for Doing Business in the Middle East

Join WTC Utah in Dubai, UAE for the largest U.S. government-led trade mission and business development forum.

Posted in BioUtah News | Tagged | Leave a comment

Certus Critical Care Awarded Two Department of Defense Grants for Development of Endovascular Device

Grants Totaling Over $3M Earmarked for Life Saving Medical Technology to Combat Massive Blood Loss

Posted in BioUtah News | Tagged | Leave a comment

MPF II NEXT Makes its Debut Investment in iVeena Delivery Systems

A clinical stage ophthalmology company, iVeena is developing disease-modifying therapeutics for a rare corneal disorder and an increasingly common form of nearsightedness

Posted in BioUtah News | Tagged | Leave a comment

Stryker: Patient impact: our inspiration

Stryker CEO, Kevin Lobo, recently shared his thoughts about his work at Stryker and what it means to help make a difference for patients

Posted in BioUtah News | Tagged | Leave a comment

BioHive Names Katelin Roberts Executive Director

BioHive, Utah’s collective of life sciences and healthcare innovation companies, today announced that Katelin Roberts will serve as the full time Executive Director, effective immediately.

Posted in BioUtah News | Tagged | Leave a comment

Recursion is Granted Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

Recursion announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for REC-4881 for the potential treatment of familial adenomatous polyposis (FAP).

Posted in BioUtah News | Tagged | Leave a comment

NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS

SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today a Phase 1 grant of $308,301 awarded by the National Institute of Health (NIH) to develop a 3-D printed, composite silicon nitride – polyetheretherketone (SN-PEEK) spinal implant.

Posted in BioUtah News | Tagged | Leave a comment

SINTX ARMOR SHIPS FIRST ORDER AND PREPARES FOR MOVE TO UTAH

SINTX Technologies, Inc., an original equipment manufacturer of advanced ceramics, announced today that its newly created and wholly-owned subsidiary, SINTX Armor, will be located in Salt Lake City, Utah and that it has signed a 10-year lease on a facility to house development and manufacturing activities for SINTX Armor.

Posted in BioUtah News | Tagged | Leave a comment

Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28

In addition to hosting a booth to promote its existing diagnostics products at the conference, the Company will also hold a press conference to introduce its upcoming at-home and point-of-care PCR device.

Posted in BioUtah News | Tagged , | Leave a comment

Owlet is changing the future of wearable devices

Recently, Owlet’s smart sock was used in a study of infant tachyarrhythmia, a condition where the heart beats much more rapidly than it should be for the level of exertion, reports Utah Business Magazine.

Posted in BioUtah News | Tagged | Leave a comment